DE LEO, SIMONE
DE LEO, SIMONE
Universita' degli Studi di MILANO
ASO Author Reflections: Total Thyroidectomy Versus Lobectomy for Differentiated Thyroid Cancer
2021 C. Colombo, S. De Leo, L. Fugazzola
Autoimmune thyroid disease during pregnancy
2017 S. De Leo, E.N. Pearce
Daily Management of Patients on Multikinase Inhibitors' Treatment
2022 C. Colombo, S. De Leo, M. Trevisan, N. Giancola, A. Scaltrito, L. Fugazzola
Endocrine-related adverse conditions induced by tyrosine kinase inhibitors.
2023 S. De Leo, M. Trevisan, C. Moneta, C. Colombo
Impact of estrogen and progesterone receptors expression on the clinical and molecular features of papillary thyroid cancer
2015 G. Vannucchi, S. De Leo, M. Perrino, S. Rossi, D. Tosi, V. Cirello, C. Colombo, G. Bulfamante, L. Vicentini, L. Fugazzola
Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability
2019 C. Colombo, M. Muzza, M.C. Proverbio, D. Tosi, D. Soranna, C. Pesenti, S. Rossi, V. Cirello, S. De Leo, N. Fusco, M. Miozzo, G. Bulfamante, L. Vicentini, S. Ferrero, A. Zambon, S. Tabano, L. Fugazzola
Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization
2014 L. Benaglia, A. Busnelli, E. Somigliana, M. Leonardi, G. Vannucchi, S. De Leo, L. Fugazzola, G. Ragni, L. Fedele
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm
2023 C. Colombo, D. Ceruti, S. DE LEO, G. Bilo, M. Trevisan, N. Giancola, C. Moneta, G. Parati, L. Persani, L. Fugazzola
Post-surgical ablative or adjuvant radioiodine therapy has no impact on outcome in 1–4 cm differentiated thyroid cancers without extrathyroidal extension
2021 S. De Leo, M. Trevisan, C. Colombo, G. Gazzano, S. Palazzo, L. Vicentini, L. Persani, L. Fugazzola
Primary Adrenal Insufficiency during Lenvatinib or Vandetanib and Improvement of Fatigue after Cortisone Acetate Therapy
2018 C. Colombo, S. De Leo, M. Di Stefano, G. Vannucchi, L. Persani, L. Fugazzola
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer
2014 A.S. Tresoldi, L.F. Sburlati, M. Rodari, M. Schinkelshoek, M. Perrino, S. De Leo, L. Montefusco, P. Colombo, M. Arosio, A.G.A. Lania, L. Fugazzola, A. Chiti
Refining calcium test for the diagnosis of medullary thyroid cancer : cutoffs, procedures, and safety
2014 C. Mian, M. Perrino, C. Colombo, E. Cavedon, G. Pennelli, S. Ferrero, S. De Leo, C. Sarais, C. Cacciatore, G.I. Manfredi, U. Verga, M. Iacobone, L. De Pasquale, M.R. Pelizzo, L. Vicentini, L. Persani, L. Fugazzola
Telomerase in differentiated thyroid cancer : promoter mutations, expression and localization
2015 M. Muzza, C. Colombo, S. Rossi, D. Tosi, V. Cirello, M. Perrino, S. De Leo, E. Magnani, E. Pignatti, B. Vigo, M. Simoni, G. Bulfamante, L. Vicentini, L. Fugazzola
The optimal range of RET mutations to be tested : European comments to the guidelines of the American Thyroid Association
2013 L. Fugazzola, S. De Leo, M. Perrino
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
2021 C. Colombo, S. De Leo, M. Di Stefano, M. Trevisan, C. Moneta, L. Vicentini, L. Fugazzola
Ultrasound-guided percutaneous ethanol injection in papillary thyroid cancer metastatic lymph-nodes
2014 G. Vannucchi, D. Covelli, M. Perrino, S. De Leo, L. Fugazzola
Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
2022 D. Zhang, C. Colombo, H. Sun, H.Y. Kim, A. Pino, S. De Leo, G. Gazzano, L. Persani, G. Dionigi, L. Fugazzola